NorthWest Biotherapeutics Inc (NWBO)

[ilovetech]

Chiugray -

To get any substantial upfront cash, it requires total exclusivity. Then you are on their schedule

I can agree with the "substantial" part requiring exclusivity.
Let's reassess. Looking at DCVAX ubiquitously, and the high margins associated with Immunotherapy, NWBO could pursue fewer, yet selective/synergistic opportunities, which meet specific criteria that fosters mutual growth.

Then you are on their schedule (for the acquirer the cash is a sunk cost), so how quickly, and/if/or, they go to market, if it cannabalizes their drug, comes into question, and questions the royalty income forecast.

The right strategy for selecting potential partners could provide the right environment condusive to mutual growth. The product sales royalties will then determine the company's value. Let's assume no money from the lawsuit, just to be conservative. Where does NWBO find the cash to transition to a full fledged product company, after assuming, no one can afford to BO NWBO?